221635-42-3 Usage
Origin
Derived from the bacterium Streptomyces caespitosus
Classification
Powerful antibiotic and antitumor agent
Mechanism of action
Causes DNA and RNA cross-linking, leading to cell death
Stomach cancer
Pancreas cancer
Bladder cancer
Lung cancer
Glaucoma
Rheumatoid arthritis
Side effects
Can cause bone marrow depression and suppress the immune system
Medical considerations
Requires careful monitoring and dosing adjustments during treatment
Check Digit Verification of cas no
The CAS Registry Mumber 221635-42-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,1,6,3 and 5 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 221635-42:
(8*2)+(7*2)+(6*1)+(5*6)+(4*3)+(3*5)+(2*4)+(1*2)=103
103 % 10 = 3
So 221635-42-3 is a valid CAS Registry Number.
221635-42-3Relevant articles and documents
DT-DIAPHORASE-ACTIVE AGENTS FOR TREATMENT OF PEDIATRIC TUMORS
-
Page/Page column 12, (2009/05/29)
The present invention is directed to methods for treating patients having a pediatric cancer, comprising administering to a patient an effective amount of the compound 2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone (RH1). The cancer can incl
COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF CANCER
-
Page/Page column 28, (2008/06/13)
The present invention relates to the use of a therapeutically effective amount of 2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone (RH1), in the manufacture of a medicament for the treatment of a cancerous condition.